Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
228.40    -9.00 (-3.79%)
Bid:
228.80
Ask:
229.00
Spread: 0.20 (0.087%)
Market Cap: £2.24b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Transaction in Own Shares

14 Apr 2022 07:00

RNS Number : 3239I
Serco Group PLC
14 April 2022
 

Serco Group plc 

Legal Entity Identifier: 549300PT2CIHYN5GWJ21

 

Transactions in own shares

 

Serco Group plc (the 'Company') announces the purchase of 32,986 ordinary shares of 2 pence each (the 'Ordinary Shares') through J.P. Morgan Securities plc on 13 April 2022.

 

The Company intends to hold all of the purchased Ordinary Shares in treasury.

 

Since the announcement of the share buy-back programme on 24 February 2022 (the 'Programme'), the Company has purchased a total of 7,436,441 Ordinary Shares.

 

Following the transactions referred to in this announcement, the Company holds 7,436,441 Ordinary Shares in treasury and has 1,210,572,347 Ordinary Shares in issue (excluding treasury shares). The total number of Ordinary Shares with voting rights will be 1,210,572,347 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The table below contains detailed information about the purchases referred to above.

 

Schedule of Purchases

 

Shares purchased:

Serco Group plc (ISIN: GB0007973794)

 

Date of purchases:

13 April 2022

 

Investment firm:

J.P. Morgan Securities plc

 

Aggregate information:

 

Venue

Aggregated number of ordinary shares purchased

Volume-weighted average price per share

Lowest price per share

Highest price per share

London Stock Exchange

32,986

148.6748

147.7000

149.7000

Ends

For further information please contact:

Paul Checketts, Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: paul.checketts@serco.com 

Marcus De Ville, Head of Media Relations, tel: +44 (0) 7738 898 550 or email: marcus.deville@serco.com 

About Serco

Serco is a leading provider of public services. Our customers are governments or others operating in the public sector. We gain scale, expertise and diversification by operating internationally across five sectors and four geographies: Defence, Justice & Immigration, Transport, Health and Citizen Services, delivered in UK & Europe, North America, Asia Pacific and the Middle East. More information can be found at www.serco.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSIJMATMTABBJT
Date   Source Headline
7th Nov 201911:22 amRNSDirector/PDMR Shareholding
7th Nov 201911:21 amRNSHolding(s) in Company
1st Nov 20199:50 amRNSTotal Voting Rights
30th Oct 201910:03 amRNSSerco signs £800m ten-year PECS contract
30th Oct 20199:51 amRNSDirector Declaration
1st Oct 201910:00 amRNSTotal Voting Rights
24th Sep 20193:42 pmRNSHolding(s) in Company
20th Sep 20199:05 amRNS£450m contract for Northern Isles Ferry Services
20th Sep 20198:31 amRNSDirectorate Change
13th Sep 201912:13 pmRNSDirector/PDMR Shareholding
11th Sep 20197:00 amRNSExtension to Australian immigration contract
2nd Sep 20191:12 pmRNSTotal Voting Rights
14th Aug 20192:20 pmRNSHolding(s) in Company
14th Aug 20192:10 pmRNSHolding(s) in Company
8th Aug 20192:13 pmRNSDirector/PDMR Shareholding
1st Aug 20192:17 pmRNSCompletion of NSBU acquisition
1st Aug 201911:00 amRNSTotal Voting Rights
31st Jul 20197:00 amRNSHalf-year Report
18th Jul 20191:13 pmRNSStatement re DFRP commercial settlement
11th Jul 20194:37 pmRNSHolding(s) in Company
8th Jul 20193:01 pmRNSHolding(s) in Company
3rd Jul 20197:00 amRNSInvestigation by SFO concludes with a DPA
2nd Jul 20193:40 pmRNSDirector/PDMR Shareholding
1st Jul 201911:19 amRNSDirector/PDMR Shareholding
1st Jul 201910:30 amRNSBlock listing Interim Review
27th Jun 20194:45 pmRNSHolding(s) in Company
27th Jun 20197:00 amRNSTrading Statement
26th Jun 201910:05 amRNSDirector/PDMR Shareholding
20th Jun 20193:10 pmRNSDirector/PDMR Shareholding
10th Jun 20193:35 pmRNSDirector/PDMR Shareholding
3rd Jun 201911:38 amRNSHolding(s) in Company
31st May 201911:25 amRNSHolding(s) in Company
28th May 20195:17 pmRNSHolding(s) in Company
23rd May 20195:26 pmRNSResults of Placing
23rd May 20197:17 amRNSPlacing of New Ordinary Shares
23rd May 20197:11 amRNSAcquisition of leading US Defence business
9th May 20191:40 pmRNSResult of AGM
8th May 20191:57 pmRNSDirector/PDMR Shareholding
29th Apr 201910:00 amRNSDirector/PDMR Shareholding
12th Apr 20194:20 pmRNSDirector/PDMR Shareholding
12th Apr 20199:50 amRNSHolding(s) in Company
11th Apr 20195:27 pmRNSHolding(s) in Company
11th Apr 20193:42 pmRNSChange in Directorships
4th Apr 201910:00 amRNSAnnual Financial Report
2nd Apr 20197:00 amRNSSerco SEA re USAF NextGen IT task order win
1st Apr 20197:00 amRNSSerco SEA Dubai Metro contract extension
28th Mar 201910:08 amRNSIssue of shares to Employee Share Ownership Trust
18th Mar 20197:00 amRNSSerco signs new AU$115m contract to operate ARC
8th Mar 20193:53 pmRNSDirector/PDMR Shareholding
8th Mar 20197:00 amRNSSerco signs new $200m contract to support US PBGC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.